Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$175M |
| 2 |
Amazon
AMZN
|
+$94.9M |
| 3 |
Evergy
EVRG
|
+$79.1M |
| 4 |
Meta Platforms (Facebook)
META
|
+$61.1M |
| 5 |
Microsoft
MSFT
|
+$56M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$283M |
| 2 |
MON
Monsanto Co
MON
|
+$197M |
| 3 |
TSMC
TSM
|
+$82.8M |
| 4 |
CSRA
CSRA Inc.
CSRA
|
+$43.5M |
| 5 |
DST
DST Systems Inc.
DST
|
+$37.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.06% |
| 2 | Financials | 14.34% |
| 3 | Healthcare | 12.26% |
| 4 | Industrials | 10.71% |
| 5 | Consumer Discretionary | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Denali Therapeutics
DNLI
$3.67B
| $1.21M | ﹤0.01% |
79,529
+13,323
| +20% | +$251K |
|
2527
TechTarget
TTGT
$323M
| $1.21M | ﹤0.01% |
42,700
| – | – |
|
2528
Universal Logistics Holdings
ULH
$480M
| $1.21M | ﹤0.01% |
46,080
+6,188
| +16% | +$147K |
|
2529
Greif Class B
GEF.B
$4.11B
| $1.21M | ﹤0.01% |
20,937
+2,590
| +14% | +$161K |
|
|
BHBK
2530
DELISTED
Blue Hills Bancorp, Inc.
BHBK
| $1.21M | ﹤0.01% |
54,253
| – | – |
|
2531
Atlanta Braves Holdings Series A
BATRA
$3.49B
| $1.2M | ﹤0.01% |
46,643
+2,953
| +7% | +$70.9K |
|
2532
Okta
OKTA
$24.6B
| $1.2M | ﹤0.01% |
23,801
-24,456
| -51% | -$1.16M |
|
2533
Fate Therapeutics
FATE
$291M
| $1.2M | ﹤0.01% |
105,300
+7,800
| +8% | +$85.9K |
|
2534
Astrana Health
ASTH
$1.78B
| $1.2M | ﹤0.01% |
+46,200
| New | +$792K |
|
|
CBIO
2535
Crescent Biopharma
CBIO
$552M
| $1.19M | ﹤0.01% |
+740
| New | +$1.27M |
|
|
OLBK
2536
DELISTED
Old Line Bancshares, Inc.
OLBK
| $1.19M | ﹤0.01% |
34,158
+19,158
| +128% | +$656K |
|
2537
Blue Bird Corp
BLBD
$2.36B
| $1.19M | ﹤0.01% |
53,295
+33,095
| +164% | +$726K |
|
|
WOW
2538
DELISTED
WideOpenWest
WOW
| $1.19M | ﹤0.01% |
123,262
+25,354
| +26% | +$204K |
|
|
WAAS
2539
DELISTED
AquaVenture Holdings Limited
WAAS
| $1.18M | ﹤0.01% |
75,953
+19,634
| +35% | +$282K |
|
2540
Geron
GERN
$821M
| $1.18M | ﹤0.01% |
343,000
+49,600
| +17% | +$189K |
|
2541
Ameresco
AMRC
$1.2B
| $1.17M | ﹤0.01% |
97,720
+18,798
| +24% | +$224K |
|
2542
Anterix
ATEX
$1.87B
| $1.17M | ﹤0.01% |
46,990
+2,965
| +7% | +$82.6K |
|
2543
Upland Software
UPLD
$13.1M
| $1.17M | ﹤0.01% |
3,390
+1,800
| +113% | +$564K |
|
|
CASA
2544
DELISTED
Casa Systems, Inc. Common Stock
CASA
| $1.17M | ﹤0.01% |
71,348
-160,770
| -69% | -$3.66M |
|
2545
Enel Chile
ENIC
$6.24B
| $1.16M | ﹤0.01% |
238,461
-190,000
| -44% | -$1.1M |
|
|
TARO
2546
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $1.16M | ﹤0.01% |
10,026
+2,054
| +26% | +$226K |
|
|
CBLK
2547
DELISTED
Carbon Black, Inc. Common Stock
CBLK
| $1.16M | ﹤0.01% |
+44,393
| New | +$1.14M |
|
|
ENZ
2548
DELISTED
Enzo Biochem, Inc.
ENZ
| $1.15M | ﹤0.01% |
221,890
+7,023
| +3% | +$42.8K |
|
2549
Lennar Class B
LEN.B
$20.1B
| $1.15M | ﹤0.01% |
28,218
-3,793
| -12% | -$157K |
|
|
SYRS
2550
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $1.15M | ﹤0.01% |
11,209
+3,535
| +46% | +$438K |
|
Similar funds
Charles Schwab's Q2 2018 Portfolio in Review
As of Q2 2018, Charles Schwab held 3,239 positions worth $137B, up 6.7% from $129B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Charles Schwab deployed $4.16B of net new capital in Q2 2018, opening 167 new positions and adding to 2,358 existing holdings. Its largest new stake was Evergy: 1,477,509 shares worth $83M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was TSMC, an estimated $82.8M trimmed.
- Charles Schwab's largest Q2 2018 buy was Evergy: 1,477,509 shares worth $83M.
- Charles Schwab added most to AT&T in Q2 2018, an estimated $175M increase.
- Charles Schwab's biggest Q2 2018 reduction was TSMC, cutting an estimated $82.8M.
- Charles Schwab fully exited Time Warner Inc in Q2 2018, selling an estimated $283M.
- Charles Schwab's ten largest holdings make up 14% of its $137B portfolio in Q2 2018.
- Charles Schwab opened 167 new positions and closed 125 in Q2 2018.
- Charles Schwab's portfolio value rose 6.7% quarter-over-quarter to $137B.
Based on Charles Schwab's 13F filing for Q2 2018, filed 8 Aug 2018.